Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... Read More


Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with... Read More


Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy ... Read More


Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxe... Read More


Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Ad... Read More


Kushinagar News: कुशीनगर में शीशम के पेड़ से लटकता मिला युवक का शव, पत्नी से हुई थी कहासुनी

कुशीनगर, अगस्त 23 -- Kushinagar News: कुशीनगर, हिन्दुस्तान टीम। कुशीनगर जिले के रामकोला थाना क्षेत्र के सिधावे ग्रामसभा के बसंतपुर गांव के बाहर सरेह में रविवार की सुबह शीशम के पेड़ की डाल से रस्सी के ... Read More


Lunar Eclipse 2026: Will Chandra Grahan Be Visible in India on August 28? Check Date, Timings, Blood Moon Visibility And Spiritual Significance

India, Aug. 23 -- The second and final lunar eclipse of 2026 will take place on August 28, but skywatchers in India will not be able to see the event. According to NASA, it will be a deep partial luna... Read More


South Africa's former world boxing champion Tete shot dead outside homePublished on: August 23, 2026 9:58 AM

Pakistan, Aug. 23 -- Former world boxing champion Zolani "Last Born" Tete was shot dead outside his home in South Africa's Eastern Cape province on Friday, police and the country's sports minister sai... Read More


Gurugram reports three fresh dengue cases, season tally reaches 29

India, Aug. 23 -- Gurugram recorded three fresh dengue cases on Saturday, taking the district's tally to 29 this season, according to the health department's latest bulletin. Officials said the monsoo... Read More


Australia-Bangladesh 2nd test: Starc and Islam take six wickets each in wild 1st dayPublished on: August 23, 2026 9:57 AM

Pakistan, Aug. 23 -- Mitchell Starc removed Bangladesh opener Shadman Islam with the first ball of the match and the veteran Australian fast bowler took six wickets in the first innings on a wild firs... Read More